Skip to main content

Table 2 Patient characteristics based on COVID-19 mortality

From: Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis

Author Country (City) Study design Study period Survived Died
Age (years) BMI (kg/m2) Dyslipidemia (n) Non-dyslipidemia (n) Age (years) BMI (kg/m2) Dyslipidemia (n) Non-dyslipidemia (n)
Almazeedi[13] Kuwait Cohort Feb24–Apr20, 2020 38.7 ± 15.1 26.8 ± 5.9 62 1015 55.0 ± 10.1 33 ± 4.7 3 16
Khalil[27] UK(London) Cohort Mar7–Apr7, 2020 63.8 (61.1–66.4) NA 34 128 75.8 (72.5–79.2) NA 16 42
Gayam[28] USA(New York) Cohort Mar1–Apr9, 2020 63 [53–73] 28.3 [25.0–33.6] 41 235 71 [62–80] 31.8 [26.5–37] 25 107
Goicoechea[29] Spain Cohort Mar12–Apr10, 2020 69 ± 14 27.2 ± 4.5 18 7 75 ± 6 25.1 ± 3.6 6 5
Santos[30] Spain (Leon) Cohort Mar1–Jun1, 2020 75.1 [69.3–75.8] NA 12 16 78.4 [74.5–83.5] NA 9 1
Wang[31] USA (New York) Cohort Mar1–Apr30, 2020 71 [18.5] 28.2 [10.2] 13 9 68 [8] 29.5 [9.9] 12 2
Ferrando[32] Spain Cohort Mar12–May16, 2020 62 [53–71] 28.6 [25.7–32.4] 55 405 68 [62–73] 27.7 [25.3–31.6] 35 168
Zhang[19] China (Beijing) Cohort Jan–Feb, 2020 NA NA 2 75 84.00 ± 8.185 NA 1 2
Hwang[33] South Korea (Daegu) Cohort Feb1–Mar25, 2020 64.62 ± 15.84 NA 10 67 76.50 ± 9.25 NA 3 23
Smith[34] New England Cohort Mar1–Apr22, 2020 63.56 30.94 107 122 73.31 29.85 60 57
Grasselli[35] Italy (Milan) Cohort Feb20–Apr22, 2020 NA NA 169 1893 NA NA 376 1550
  1. Data are expressed as mean ± standard deviation; median [interquartile range]; mean (95%Confidence interval)
  2. COVID-19 coronavirus disease, NA not available, n number, BMI body mass index